EUVIMEDEUVIMED entdecken
Crossref

Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices

Jules Mesnier, Julien Ternacle, Asim N Cheema, Francisco Campelo-Parada, Marina Urena, Gabriela Veiga-Fernandez, Luis Nombela-Franco, Antonio J Munoz-Garcia, Victoria Vilalta, Ander Regueiro, David Del Val, Lluis Asmarats und 19 weitere

JACC: Cardiovascular Interventions · 2023

DOI: 10.1016/j.jcin.2023.07.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2023. Verfasst von Jules Mesnier und 30 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The burden of cardiac death after transcatheter aortic valve replacement (TAVR), particularly from advanced heart failure (HF) and sudden cardiac death (SCD), remains largely unknown. OBJECTIVES: This study sought to evaluate the incidence and predictors of SCD and HF-related death in TAVR recipients treated with newer-generation devices. METHODS: This study included a total of 5,421 consecutive patients who underwent TAVR with newer-generation devices using balloon (75.7%) or self-expandable (24.3%) valves. RESULTS: After a median follow-up of 2 (IQR: 1-3) years, 976 (18.0%) patients had died, 50.8% from cardiovascular causes. Advanced HF and SCD accounted for 11.6% and 7.5% of deaths, respectively. Independent predictors of HF-related death were atrial fibrillation (HR: 2.17; 95% CI: 1.47-3.22; P < 0.001), prior pacemaker (HR: 1.79; 95% CI: 1.10-2.92; P = 0.01), reduced left ventricular ejection fraction (HR: 1.08 per 5% decrease; 95% CI: 1.01-1.14; P = 0.02), transthoracic approach (HR: 2.50; 95% CI: 1.37-4.55; P = 0.003), and new-onset persistent left bundle branch block (HR: 1.85; 95% CI: 1.14-3.02; P = 0.01). Two baseline characteristics (diabetes, HR: 1.81; 95% CI: 1.13-2.89; P = 0.01; and chronic kidney disease, HR: 1.72; 95% CI: 1.02-2.90; P = 0.04) and 3 procedural findings (valve in valve, HR: 2.17; 95% CI: 1.01-4.64; P = 0.04; transarterial nontransfemoral approach, HR: 2.23; 95% CI: 1.23-4.48; P = 0.01; and periprocedural ventricular arrhythmia, HR: 7.19; 95% CI: 2.61-19.76; P < 0.001) were associated with an increased risk of SCD after TAVR. CONCLUSIONS: Advanced HF and SCD accounted for a fifth of deaths after TAVR in contemporary practice. Potentially treatable factors leading to increased risk of HF deaths and SCD were identified, such as arrhythmia/dyssynchrony factors for HF and valve-in-valve TAVR or periprocedural ventricular arrhythmias for SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHumansStroke VolumeRisk FactorsVentricular Function, LeftTreatment OutcomeArrhythmias, CardiacDeath, Sudden, CardiacAortic Valve

Stichwörter der Autor:innen

aortic stenosisheart failuresudden cardiac deathtranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Hôpital Cardiologique Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France.
  • Southlake Regional Health Centre, St. Michael's Hospital Toronto, Newmarket, Ontario, Canada.
  • Hôpital Rangueil, CHU Toulouse, Toulouse, France.
  • Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Zitieren

APA

Mesnier, J., Ternacle, J., Cheema, A. N., Campelo-Parada, F., Urena, M., Veiga-Fernandez, G., Nombela-Franco, L., Munoz-Garcia, A. J., Vilalta, V., Regueiro, A., Del Val, D., Asmarats, L., Del Trigo, M., Serra, V., Bonnet, G., Jonveaux, M., Rezaei, E., Matta, A., Himbert, D., …, & Rodés-Cabau, J. (2023). Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2023.07.015

Vancouver

Mesnier J, Ternacle J, Cheema AN, Campelo-Parada F, Urena M, Veiga-Fernandez G, et al. Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices. JACC: Cardiovascular Interventions. 2023. doi:10.1016/j.jcin.2023.07.015

BibTeX
@article{Mesnier2023,
  author = {Mesnier, Jules and Ternacle, Julien and Cheema, Asim N and Campelo-Parada, Francisco and Urena, Marina and Veiga-Fernandez, Gabriela and Nombela-Franco, Luis and Munoz-Garcia, Antonio J and Vilalta, Victoria and Regueiro, Ander and Del Val, David and Asmarats, Lluis and Del Trigo, Maria and Serra, Vicenç and Bonnet, Guillaume and Jonveaux, Melchior and Rezaei, Effat and Matta, Anthony and Himbert, Dominique and de la Torre Hernandez, Jose Maria and Tirado-Conte, Gabriela and Fernandez-Nofrerias, Eduard and Vidal, Pablo and Alfonso, Fernando and Gutierrez-Alonso, Lola and Oteo, Juan Francisco and Belahnech, Yassin and Mohammadi, Siamak and Philippon, François and Modine, Thomas and Rodés-Cabau, Josep},
  title = {Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices},
  journal = {JACC: Cardiovascular Interventions},
  year = {2023},
  doi = {10.1016/j.jcin.2023.07.015}
}
Kostenlos starten →